Business context and reporting period
This is Tempur Sealy International, Inc.’s Form 10-K for the fiscal year ended December 31, 2023; it is not a quarterly report. The request metadata names SOMNIGROUP INTERNATIONAL INC., which does not match the registrant identified in the filing. Tempur Sealy designs, manufactures, distributes, and retails bedding products under brands including Tempur-Pedic, Sealy, and Stearns & Foster. It reports North America and International segments and sells through wholesale and direct channels.
Key financial metrics
All amounts are U.S. dollars. Fiscal 2023 comparisons are with fiscal 2022 unless noted.
| Metric | 2023 | 2022 |
|---|---|---|
| Net sales | $4,925.4 million | $4,921.2 million |
| Gross profit / margin | $2,128.7 million / 43.2% | $2,049.6 million / 41.6% |
| Operating income / margin | $607.2 million / 12.3% | $680.6 million / 13.8% |
| Net income attributable to Tempur Sealy | $368.1 million | $455.7 million |
| Diluted EPS | $2.08 | $2.53 |
| Net cash from operating activities | $570.3 million | $378.8 million |
| Capital expenditures | $185.4 million | $306.5 million |
| Net interest expense | $129.9 million | $103.0 million |
Non-GAAP adjusted operating income was $695.1 million, adjusted net income $425.6 million, adjusted diluted EPS $2.40, and adjusted EBITDA $877.3 million. These measures exclude items including acquisition costs and cybersecurity-related expenses; they supplement, not replace, GAAP results.
North America sales declined 0.8% to $3,855.5 million; operating income was $643.1 million. International sales rose 3.4% to $1,069.9 million; operating income fell to $170.9 million. Direct sales were $1,179.3 million, or 23.9% of consolidated sales.
At year-end, cash was $74.9 million, working capital $195.0 million, and total debt $2,593.6 million. Reported liquidity was $1,041.3 million, including $966.4 million available on the revolving facility. Net leverage under the credit agreement was 2.87 times adjusted EBITDA; the company reported compliance with its debt covenants.
Material changes versus the prior comparable period
- Sales were essentially flat, while gross margin improved 160 basis points, primarily on lower commodity costs and pricing actions.
- Operating income fell 10.8% and net income fell 19.2%. Operating expenses increased 11.1%, including $49.0 million of Mattress Firm transaction costs and an $11.0 million fair-value remeasurement; higher interest expense also weighed on results.
- Operating cash flow increased by $191.5 million, partly due to favorable changes in working capital, including lower inventory. Capital expenditures declined as capacity expansion projects neared completion.
- Total debt decreased from $2,830.8 million. The company refinanced its credit agreement in October 2023 and repaid a net $250.8 million under credit facilities during the year.
Outlook, risks, contingencies, and unusual items
- Management expects ongoing inflation and interest-rate pressures in 2024, with consumer confidence expected to stabilize. It expects 2024 capital expenditures of approximately $150 million, including $110 million for maintenance.
- The pending Mattress Firm acquisition is valued at approximately $4.0 billion, comprising about $2.7 billion cash and 34.2 million shares. Closing was expected in the second half of 2024, subject to regulatory approval. The company expects 2024 leverage of 3.0–3.25 times and targets returning to 2.0–3.0 times within the first 12 months after closing. In February 2024, it amended its credit agreement to add a $625 million delayed-draw term loan and $40 million of incremental revolving availability.
- The company plans 2024 product launches, including Tempur-Pedic Adapt in North America and a broader Tempur product rollout internationally. Execution, consumer acceptance, and launch costs are risks.
- A July 2023 cybersecurity incident temporarily disrupted operations and generated $14.3 million of costs. Management reported no material impact on 2023 financial results; insurance coverage is limited to $5.0 million, and no claim had yet been submitted.
- The Danish tax dispute for 2012–2022 was formally resolved in 2023. The settlement generated tax benefits and receivables; $4.5 million of gross unrecognized tax benefits remained at year-end. The company said pending legal and administrative proceedings, in aggregate, were not expected to have a material adverse effect.
- Other key exposures include customer concentration (the top five customers represented approximately 32% of sales; Mattress Firm alone exceeded 15%), competition, raw-material and supply-chain volatility, variable-rate debt, foreign exchange, labor and pension-plan risks, and regulatory approval of the acquisition. Share repurchases were suspended in connection with the pending acquisition; a $0.13-per-share dividend was declared for first-quarter 2024.
Important facts for investors to verify
- Confirm the registrant identity: the supplied metadata says SOMNIGROUP INTERNATIONAL INC., while the filing is for Tempur Sealy International, Inc. (NYSE: TPX).
- Track Mattress Firm regulatory review, required divestitures or other conditions, financing, dilution, closing timing, and expected synergies.
- Assess whether revenue trends and International operating performance improve, and whether gross-margin gains persist as costs and product mix change.
- Review leverage, variable-rate exposure, debt covenant headroom, and liquidity needs following any acquisition financing.
- Monitor the consequences and any insurance recovery related to the cybersecurity incident, and the realization of tax receivables and benefits.